
    
      The Accel AV study is a prospective, single-arm, global, multi-center clinical study to
      characterize the chronic AV synchrony in subjects implanted with the market released Micra AV
      system. The study is planned to be conducted in the US and Hong Kong. Overall, the study is
      expected to be conducted at approximately 20 centers.The expected total study duration is
      approximately 12-15 months, representing the time necessary to enroll the target sample size
      and to complete the 3-month follow-up visit.
    
  